Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 178

1.

The editor's roundtable: expanded versus standard lipid panels in assessing and managing cardiovascular risk.

Sulkes D, Brown BG, Krauss RM, Segrest JP, Sniderman AD, Roberts WC.

Am J Cardiol. 2008 Mar 15;101(6):828-42. doi: 10.1016/j.amjcard.2007.12.006. Review. No abstract available.

PMID:
18328849
2.

The editor's roundtable: lipid management beyond statins-reducing residual cardiovascular risk.

Friedewald VE Jr, Ballantyne CM, Davidson MH, Guyton JR, Roberts WC.

Am J Cardiol. 2008 Sep 1;102(5):559-67. doi: 10.1016/j.amjcard.2008.06.028. No abstract available.

PMID:
18721512
3.

Atherogenic dyslipidemia.

Hayden MR.

J Cardiometab Syndr. 2006 Summer;1(3):166-7. No abstract available.

4.

Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction.

Basile J, Houston M, Ferrario CM.

J Cardiometab Syndr. 2006 Fall;1(5):358-61. No abstract available.

5.
6.
7.

CVD risk factors in rural women.

Roddy SJ, Walker SN, Larsen J, Lindsey A, Shurmur S, Yates B.

Nurse Pract. 2007 Jun;32(6):53-5. No abstract available.

PMID:
17557029
8.

Management of dyslipidaemia - evidence and practical recommendations.

Nestel PJ, O'Brien R, Nelson M.

Aust Fam Physician. 2008 Jul;37(7):521-7. Review.

PMID:
18592069
9.

Fibrates consistently lower risk of cardiovascular events across high-risk groups.

[No authors listed]

Cardiovasc J Afr. 2010 May-Jun;21(3):174. No abstract available.

10.

Increase in lipid-lowering treatment rates among TRICARE beneficiaries: a population-based study.

Devine J, Linton A, Mistry H, Napier J, Trice S, Bacon T.

Pharmacoepidemiol Drug Saf. 2009 Oct;18(10):891-9. doi: 10.1002/pds.1786.

PMID:
19634117
11.

European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).

Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen mL, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgözoglu L, Wiklund O, Zampelas A; European Society of Cardiology (ESC).; European Association for Cardiovascular Prevention and Rehabilitation (EACPR).; Council on Cardiovascular Nursing.; European Association for Study of Diabetes (EASD).; International Diabetes Federation Europe (IDF-Europe).; European Stroke Initiative (EUSI).; Society of Behavioural Medicine (ISBM).; European Society of Hypertension (ESH).; WONCA Europe (European Society of General Practice/Family Medicine).; European Heart Network (EHN).; European Atherosclerosis Society (EAS)..

Eur J Cardiovasc Prev Rehabil. 2007 Sep;14 Suppl 2:S1-113. No abstract available.

PMID:
17726407
12.

New ESC/EAS Guidelines for the management of dyslipidaemias - any controversies behind the consensus?

Reiner Z.

Eur J Cardiovasc Prev Rehabil. 2011 Oct;18(5):724-7. doi: 10.1177/1741826711418946. No abstract available.

PMID:
21945917
13.

European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).

Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen ML, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgözoglu L, Wiklund O, Zampelas A; European Society of Cardiology (ESC).; European Association for Cardiovascular Prevention and Rehabilitation (EACPR).; Council on Cardiovascular Nursing.; European Association for Study of Diabetes (EASD).; International Diabetes Federation Europe (IDF-Europe).; European Stroke Initiative (EUSI).; International Society of Behavioural Medicine (ISBM).; European Society of Hypertension (ESH).; European Society of General Practice/Family Medicine (ESGP/FM/WONCA).; European Heart Network (EHN)..

Eur J Cardiovasc Prev Rehabil. 2007 Sep;14 Suppl 2:E1-40. No abstract available.

PMID:
17726406
14.

Common questions in managing hyperlipidemia.

Rosen IM, Sams RW 2nd.

Prim Care. 2006 Dec;33(4):903-21. Review.

PMID:
17169673
15.

Lipid screening and cardiovascular health in childhood.

Daniels SR, Greer FR; Committee on Nutrition..

Pediatrics. 2008 Jul;122(1):198-208. doi: 10.1542/peds.2008-1349. Review.

PMID:
18596007
16.

Universal lipid screening in children and adolescents: a baby step toward primordial prevention?

Saenger AK.

Clin Chem. 2012 Aug;58(8):1179-81. doi: 10.1373/clinchem.2012.182287. No abstract available.

17.

Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy.

Fazio S.

Clin Ther. 2008 Feb;30(2):294-306. doi: 10.1016/j.clinthera.2008.02.004. Review.

PMID:
18343268
18.

The use of lipid-lowering drug therapy in children and adolescents.

Avis HJ, Vissers MN, Wijburg FA, Kastelein JJ, Hutten BA.

Curr Opin Investig Drugs. 2009 Mar;10(3):224-31. Review.

PMID:
19333879
19.

Treatment of dyslipidemia: we don't know all we think we know.

LeLorier J.

Can J Cardiol. 2006 Jul;22(9):737-8. No abstract available.

20.

Cardiovascular disease preventive measures for the older patient: an epidemiologic perspective.

Kannel WB.

Am J Geriatr Cardiol. 2006 Nov-Dec;15(6):382-8. Review. No abstract available.

PMID:
17086034
Items per page

Supplemental Content

Support Center